RHYTHM PHARMACEUTICALS, INC. (RYTM) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Tue, Nov 3, 2026before open 34 8-K
Q2 FY2026Tue, Aug 4, 2026before open 35 8-K
Q1 FY2026Tue, May 5, 2026before open 35 8-K
Q4 FY2025Thu, Feb 26, 2026before open 57 8-K
Q3 FY2025Tue, Nov 4, 2025before open 35 8-K
Q2 FY2025Tue, Aug 5, 2025before open 36 8-K
Q1 FY2025Wed, May 7, 2025before open 37 8-K
Q4 FY2024Wed, Feb 26, 2025before open 57 8-K

What they guided beta

Q3 FY2026 "On August 11, 2026, the Company announced that IMCIVREE received expanded Marketing Authorization in the United Kingdom for the treatment of obesity and control of hunger in patients with acquired HO due to hypothalamic injury or impairment; Anticipated Upcoming Milestones Rhythm expects to achieve the following near-term milestones:" exhibit
Q3 FY2026 "Guidance: For the year ending December 31, 2026, Rhythm anticipates approximately $360 million to $380 million in Non-GAAP Operating Expenses." exhibit
Q3 FY2026 "Based on its current operating plans, Rhythm expects that its cash, cash equivalents and short-term investments as of September 30, 2026 will be sufficient to fund the Company’s planned operations for at least 24 months." exhibit
Q2 FY2026 "Anticipate launch of IMCIVREE for acquired HO in Japan pending a decision by Japan's Ministry of Health, Labour and Welfare (MHLW) by year-end 2026;" exhibit
Q2 FY2026 "Anticipate country-level launches of IMCIVREE for acquired HO in Europe beginning in 2027." exhibit
Q2 FY2026 "Guidance: For the year ending December 31, 2026, Rhythm anticipates approximately $363 million to $397 million in Non-GAAP Operating Expenses." exhibit
Q2 FY2026 "Based on its current operating plans, Rhythm expects that its cash, cash equivalents and short-term investments as of June 30, 2026 will be sufficient to fund the Company’s planned operations for at least 24 months." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/RYTM
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/RYTM

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

RYTM earnings date badge

HTML

<a href="https://veritasdata.dev/company/RYTM/"><img src="https://veritasdata.dev/embed/RYTM.svg" alt="RYTM earnings date" width="240" height="56"></a>

Markdown

[![RYTM earnings date](https://veritasdata.dev/embed/RYTM.svg)](https://veritasdata.dev/company/RYTM/)

Script

<script async src="https://veritasdata.dev/embed/RYTM.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/RYTM"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.